Search

everythinglearnresearchcommunity

for

Search:↓

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Premature hair greying may indicate a higher risk of metabolic problems.

Wet cupping blood has different components than regular venous blood, which might affect skin disorder treatments.

Fetuin A levels are higher in PCOS patients, while asprosin levels show no difference.

Different human traits like skin color and hair type vary between populations due to genetic adaptations to the environment.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Melatonin improved mental health and metabolism in women with PCOS.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

A cholesterol-free liposomal platform using protopanaxadiol effectively promotes hair growth and treats alopecia.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Women with early onset androgenetic alopecia have worse lipid profiles.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Spaceflight can harm skin health by altering gene expression, affecting DNA, mitochondria, and skin barriers.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Different ligands change the shape of the TRPV3 ion channel in unique ways.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.